WO2005123033A3 - Fine particles of cilostazol and processes for production thereof - Google Patents

Fine particles of cilostazol and processes for production thereof Download PDF

Info

Publication number
WO2005123033A3
WO2005123033A3 PCT/IB2005/001738 IB2005001738W WO2005123033A3 WO 2005123033 A3 WO2005123033 A3 WO 2005123033A3 IB 2005001738 W IB2005001738 W IB 2005001738W WO 2005123033 A3 WO2005123033 A3 WO 2005123033A3
Authority
WO
WIPO (PCT)
Prior art keywords
cilostazol
processes
production
fine particles
relates
Prior art date
Application number
PCT/IB2005/001738
Other languages
French (fr)
Other versions
WO2005123033A2 (en
Inventor
Yatendra Kumar
Mohan Prasad
Asok Nath
Original Assignee
Ranbaxy Lab Ltd
Yatendra Kumar
Mohan Prasad
Asok Nath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Yatendra Kumar, Mohan Prasad, Asok Nath filed Critical Ranbaxy Lab Ltd
Publication of WO2005123033A2 publication Critical patent/WO2005123033A2/en
Publication of WO2005123033A3 publication Critical patent/WO2005123033A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to fine particles of cilostazol and processes for production thereof.
PCT/IB2005/001738 2004-06-18 2005-06-20 Fine particles of cilostazol and processes for production thereof WO2005123033A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1152DE2004 2004-06-18
IN1152/DEL/2004 2004-06-18

Publications (2)

Publication Number Publication Date
WO2005123033A2 WO2005123033A2 (en) 2005-12-29
WO2005123033A3 true WO2005123033A3 (en) 2006-07-20

Family

ID=35510242

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/001738 WO2005123033A2 (en) 2004-06-18 2005-06-20 Fine particles of cilostazol and processes for production thereof

Country Status (1)

Country Link
WO (1) WO2005123033A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI697337B (en) * 2013-08-07 2020-07-01 學校法人近畿大學 Process for produing nano particle or nano-particle composition, and process for manufacturing stent or balloon catheter

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045549A1 (en) * 2001-06-29 2003-03-06 Stowell Grayson Walker Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US20030166937A1 (en) * 2000-08-14 2003-09-04 Marioara Mendelovici Substantially pure cilostazol and processes for making same
WO2004024716A1 (en) * 2002-09-10 2004-03-25 Otsuka Pharmaceutical Co., Ltd. Process for producing cilostazol

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166937A1 (en) * 2000-08-14 2003-09-04 Marioara Mendelovici Substantially pure cilostazol and processes for making same
US20030045549A1 (en) * 2001-06-29 2003-03-06 Stowell Grayson Walker Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2004024716A1 (en) * 2002-09-10 2004-03-25 Otsuka Pharmaceutical Co., Ltd. Process for producing cilostazol
EP1489080A1 (en) * 2002-09-10 2004-12-22 Otsuka Pharmaceutical Co., Ltd. Process for producing cilostazol

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 91, no. 12, 2002, pages 2481 - 2488, XP002378476 *

Also Published As

Publication number Publication date
WO2005123033A2 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
WO2007074437A8 (en) Methods for production of metal oxide nano particles, and nano particles and preparations produced thereby
WO2006119329A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
WO2006099557A3 (en) Design and manufacturing processes of backplane for segment displays
WO2007120423A3 (en) Production of quinone derived compounds in oleaginous yeast and fungi
WO2006124748A3 (en) Multicyclic compounds and methods of their use
EP2072462A4 (en) Process for producing dispersion of fine metal compound particles and the dispersion
UA90293C2 (en) Process for preparing lansoprazole
IL181303A (en) Method for the production of dihydropteridinones and some such compounds
EP1854814A4 (en) Hyper-branched polymer and process for production of the same
WO2007079215A3 (en) Methods and compositions for removal of arsenic and heavy metals from water
HK1105117A1 (en) Filter and production methods of the same
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
IL181935A0 (en) Composition containing fine particles and process for producing the same
NO20053796D0 (en) Process for the production of particles
ZA200805055B (en) Methods for production of titanium oxide particlesMethods for production of titanium oxide particles, and particles and preparations produced thereby , and particles and preparations produced thereby
WO2008150537A3 (en) Silica particles and methods of making and using the same
EP2154166A4 (en) Molecule-responsive gel fine particles, process for production of the same and use thereof
EP2062948B8 (en) Surface modifier for metal oxide particles and method for modifying surface of metal oxide particles using the same
TW200732410A (en) Sprayable acoustic compositions
HK1121987A1 (en) Highly porous coated fine particles, composition, and method of production
WO2007101161A8 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1874948A4 (en) PROCESS FOR THE PRODUCTION OF y-GLUTAMYLCYSTEINE
WO2008061019A3 (en) Modulators of neuronal regeneration
IL185274A0 (en) Agglomerated starch composition and methods for the production thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase